(3-amino-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl)methanol;8-chloroimidazo[1,2-a]pyrazine;1-(4-fluorophenyl)-N-[(3S)-3-(hydroxymethyl)-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl]pyrazole-3-carboxamide;1-(4-fluorophenyl)pyrazole-3-carboxylic acid;(1-imidazo[1,2-a]pyrazin-8-yl-3-methylpyrrolidin-3-yl)methanol;methane;(3-methylpyrrolidin-3-yl)methanol;hydrochloride
C68H84Cl2F2N22O7 — CID 158620888
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3-amino-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl)methanol;8-chloroimidazo[1,2-a]pyrazine;1-(4-fluorophenyl)-N-[(3S)-3-(hydroxymethyl)-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl]pyrazole-3-carboxamide;1-(4-fluorophenyl)pyrazole-3-carboxylic acid;(1-imidazo[1,2-a]pyrazin-8-yl-3-methylpyrrolidin-3-yl)methanol;methane;(3-methylpyrrolidin-3-yl)methanol;hydrochloride
(3-amino-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl)methanol;8-chloroimidazo[1,2-a]pyrazine;1-(4-fluorophenyl)-N-[(3S)-3-(hydroxymethyl)-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl]pyrazole-3-carboxamide;1-(4-fluorophenyl)pyrazole-3-carboxylic acid;(1-imidazo[1,2-a]pyrazin-8-yl-3-methylpyrrolidin-3-yl)methanol;methane;(3-methylpyrrolidin-3-yl)methanol;hydrochloride (PubChem CID 158620888) has the molecular formula C68H84Cl2F2N22O7 and a molecular weight of 1430.47 g/mol. Its IUPAC name is (3-amino-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl)methanol;8-chloroimidazo[1,2-a]pyrazine;1-(4-fluorophenyl)-N-[(3S)-3-(hydroxymethyl)-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl]pyrazole-3-carboxamide;1-(4-fluorophenyl)pyrazole-3-carboxylic acid;(1-imidazo[1,2-a]pyrazin-8-yl-3-methylpyrrolidin-3-yl)methanol;methane;(3-methylpyrrolidin-3-yl)methanol;hydrochloride.
Molecular Properties
| Compound Name | (3-amino-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl)methanol;8-chloroimidazo[1,2-a]pyrazine;1-(4-fluorophenyl)-N-[(3S)-3-(hydroxymethyl)-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl]pyrazole-3-carboxamide;1-(4-fluorophenyl)pyrazole-3-carboxylic acid;(1-imidazo[1,2-a]pyrazin-8-yl-3-methylpyrrolidin-3-yl)methanol;methane;(3-methylpyrrolidin-3-yl)methanol;hydrochloride |
|---|---|
| PubChem CID | 158620888 |
| Molecular Formula | C68H84Cl2F2N22O7 |
| Molecular Weight | 1430.47 g/mol |
| Exact Mass | 1428.62 |
| IUPAC Name | (3-amino-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl)methanol;8-chloroimidazo[1,2-a]pyrazine;1-(4-fluorophenyl)-N-[(3S)-3-(hydroxymethyl)-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl]pyrazole-3-carboxamide;1-(4-fluorophenyl)pyrazole-3-carboxylic acid;(1-imidazo[1,2-a]pyrazin-8-yl-3-methylpyrrolidin-3-yl)methanol;methane;(3-methylpyrrolidin-3-yl)methanol;hydrochloride |
| SMILES | C.C.CC1(CO)CCN(c2nccn3ccnc23)C1.CC1(CO)CCNC1.Cl.Clc1nccn2ccnc12.NC1(CO)CCN(c2nccn3ccnc23)C1.O=C(N[C@@]1(CO)CCN(c2nccn3ccnc23)C1)c1ccn(-c2ccc(F)cc2)n1.O=C(O)c1ccn(-c2ccc(F)cc2)n1 |
| InChI | InChI=1S/C21H20FN7O2.C12H16N4O.C11H15N5O.C10H7FN2O2.C6H4ClN3.C6H13NO.2CH4.ClH/c22-15-1-3-16(4-2-15)29-9-5-17(26-29)20(31)25-21(14-30)6-10-28(13-21)19-18-23-7-11-27(18)12-8-24-19;1-12(9-17)2-5-16(8-12)11-10-13-3-6-15(10)7-4-14-11;12-11(8-17)1-4-16(7-11)10-9-13-2-5-15(9)6-3-14-10;11-7-1-3-8(4-2-7)13-6-5-9(12-13)10(14)15;7-5-6-9-2-4-10(6)3-1-8-5;1-6(5-8)2-3-7-4-6;;;/h1-5,7-9,11-12,30H,6,10,13-14H2,(H,25,31);3-4,6-7,17H,2,5,8-9H2,1H3;2-3,5-6,17H,1,4,7-8,12H2;1-6H,(H,14,15);1-4H;7-8H,2-5H2,1H3;2*1H4;1H/t21-;;;;;;;;/m0......../s1 |
| InChIKey | AYDILJVQAMRRLV-WSCDEDTISA-N |
| XLogP | 6.76 |
| TPSA | 351.49 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 101 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1430.47 |
| LogP ≤ 5 | 6.76 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 27 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158620888 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.